Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-12-01T00:33:47.172Z Has data issue: false hasContentIssue false

The Effect of Isoniazid on Depressive States

Published online by Cambridge University Press:  08 February 2018

A. J. Oldham*
Affiliation:
Cane Hill Hospital, Coulsdon, Surrey

Extract

Isonicotinyl Hydrazide or Isoniazid has for some years now been used in conjunction with other compounds in the treatment of pulmonary tuberculosis. During this treatment certain workers (Robitzek et al., 1952) noted the development of a state of euphoria in their patients. Since Isoniazid was known to exert toxic effects on nervous tissue (Gammen et al., 1953) the hypothesis was made that the substance might be capable of producing an elevation of mood by direct action on the central nervous system. Acting on this hypothesis, Salzer and Lurie (1953) treated a group of patients suffering from various depressive conditions with Isoniazid given orally in the dosage of 50 mgm. t.d.s. for one week. If no toxic effects occurred the dosage was raised to 100 mgm. t.d.s. for a further two weeks, while in a few cases only higher doses were given. These workers maintained this level of dosage in order to avoid the advent of toxic side effects. Their results, which will be discussed later in this paper, led them to the conclusion that isoniazid had a specific therapeutic effect upon certain depressive disorders.

The object of this study, arising out of the work mentioned, was to carry out an initial survey of the effects of isoniazid on the affective component of various depressive states. If any demonstrable therapeutic action had been noted a larger, controlled, and more systematic study would have been undertaken but in view of the results obtained this further project has now been abandoned.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1955 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bennett, I. F., Cohen, D., and Storer, E., Arch. Neurol. Psychiat., 1954, 71, 54.Google Scholar
Gammen, G. D., Burge, F. W., and King, G., Arch. Neurol. Psychiat, 1953, 70, 64.Google Scholar
Robitzek, E. H., Selikoff, I. J., and Ornstein, G. G., Quart. Bull. Sea View Hosp., 1952, 8, 27.Google Scholar
Salzer, H. H., and Lurie, M. L., Arch. Neurol. Psychiat., 1953, 70, 317.CrossRefGoogle Scholar
Silverman, M., J. Neurol. Neurosurg. Psychiat., 1954, 17, 145.Google Scholar
Wassersug, J., and Hunt, B., New Eng. J. Med., 1953, 249, 1051.Google Scholar
Wilson, W. P., Dis. Nerv. Sys., 1953, 14, 278.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.